Skip to main content
Clinical Epigenetics logoLink to Clinical Epigenetics
. 2021 Aug 3;13:151. doi: 10.1186/s13148-021-01141-2

Correction to: Genome-wide DNA methylome analysis identifies methylation signatures associated with survival and drug resistance of ovarian cancers

David W Chan 1,, Wai-Yip Lam 2, Fushun Chen 1, Mingo M H Yung 1, Yau-Sang Chan 1, Wai-Sun Chan 1, Fangfang He 1, Stephanie S Liu 1, Karen K L Chan 1, Benjamin Li 2, Hextan Y S Ngan 1,3,
PMCID: PMC8330114  PMID: 34344477

Correction to: Clin Epigenet (2021) 13:142 10.1186/s13148-021-01130-5

Following publication of the original article [1], the authors identified an error in the result section.

The sentence currently read:

Indeed, the hypermethylated gene promoter regions of CLDN16 […].

The sentence should read:

Indeed, the hypomethylated gene promoter regions of CLDN16 […].

The original article [1] has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

David W. Chan, Email: dwchan@hku.hk

Hextan Y. S. Ngan, Email: hysngan@hku.hk

Reference

  • 1.Chan, et al. Clin Epigenet. 2021;13:142. doi: 10.1186/s13148-021-01130-5. [DOI] [Google Scholar]

Articles from Clinical Epigenetics are provided here courtesy of BMC

RESOURCES